www.summitMD.com

AMI

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans
Eur Heart J, 2010. 31(6): p. 659-66.
G. K. Wang, et al.,

Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction
Am J Cardiol, 2010. 105(1): p. 1-9.
G. Haltern, et al.,

Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease
JACC Cardiovasc Interv, 2010. 3(1): p. 22-31.
E. L. Hannan, et al.,

Determinants of cardiac catheterization use in older medicare patients with acute myocardial infarction
Circ Cardiovasc Qual Outcomes, 2010. 3(1): p. 54-62.
D. T. Ko, et al.,

Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction
Am Heart J, 2010. 159(1): p. 55-62.
J. R. Harkness, et al.,

Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding
Circulation, 2010.
I. Hagedorn, et al.,

Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction
Free Radic Biol Med, 2010. 48(2): p. 223-9.
L. N. Paton, et al.,

Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study
Heart, 2010. 96(3): p. 190-5.
J. D. Haeck, et al.,

Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction
Circulation, 2010. 121(6): p. 775-83.
M. Oostendorp, et al.,

Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide
Am Heart J, 2010. 159(1): p. 47-54.
K. Kruszewski, et al.,

Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial
Am Heart J, 2010. 159(1): p. 131-40.
R. Jarai, et al.,

Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
Scand J Clin Lab Invest, 2010. 70(2): p. 80-6.
A. Hedegaard, et al.,

Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement
J Cardiovasc Med (Hagerstown), 2010. 11(1): p. 7-13.
C. Lazzeri, et al.,

Primary Angioplasty Versus Fibrinolysis in Acute Myocardial Infarction. Long-Term Follow-Up in the Danish Acute Myocardial Infarction 2 Trial
Circulation, 2010.
P. H. Nielsen, et al.,

Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy
Clin Res Cardiol, 2010. 99(1): p. 13-9.
G. Ndrepepa, et al.,

Racial differences in women's prodromal and acute symptoms of myocardial infarction
Am J Crit Care, 2010. 19(1): p. 63-73.
J. C. McSweeney, et al.,

Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction
Am Heart J, 2010. 159(3): p. 354-60.
M. Taljaard, et al.,

ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial
Can J Cardiol, 2010. 26(1): p. e7-12.
D. Y. So, et al.,

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls
Eur Heart J, 2009. 30(17): p. 2137-46.
S. Parish, et al.,

Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network
Eur Heart J, 2009. 30(1): p. 33-43.
P. Ortolani, et al.,

C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Eur Heart J, 2009. 30(10): p. 1180-6.
S. Orn, et al.,

Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study
Eur Heart J, 2009. 30(13): p. 1656-65.
G. L. Nicolosi, et al.,

Acute myocardial infarction and cardiogenic shock caused by a mobile thrombus in the ascending aorta unassociated with atherosclerosis
Eur Heart J, 2009. 30(20): p. 2440.
S. Nakamori, et al.,

Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
Eur Heart J, 2009. 30(7): p. 757-64.
M. Majidi, et al.,

Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction
Eur Heart J, 2009. 30(23): p. 2854-60.
H. S. Lim, et al.,

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
Eur Heart J, 2009. 30(9): p. 1057-65.
S. Q. Khan, et al.,

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Eur Heart J, 2009. 30(21): p. 2575-83.
E. M. Jolicoeur, et al.,

Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction
Eur Heart J, 2009. 30(6): p. 689-98.
H. V. Huikuri, et al.,

Gender differences in sympathetic neural activation following uncomplicated acute myocardial infarction
Eur Heart J, 2009. 30(14): p. 1764-70.
A. J. Hogarth, et al.,

Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study
Eur Heart J, 2009. 30(6): p. 662-70.
L. Herbots, et al.,

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation
Eur Heart J, 2009.
S. Grajek, et al.,

Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction
Eur Heart J, 2009. 30(12): p. 1440-9.
J. Ganame, et al.,

Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study
Eur Heart J, 2009. 30(5): p. 566-75.
S. Funaro, et al.,

Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?
Eur Heart J, 2009. 30(15): p. 1828-30.
A. V. Finn, et al.,

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials
Eur Heart J, 2009. 30(22): p. 2705-13.
G. De Luca, E. Navarese and P. Marino,

Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up
Eur Heart J, 2009. 30(13): p. 1598-606.
E. Bonnefoy, et al.,

Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)
Eur Heart J, 2009. 30(12): p. 1450-6.
C. Berry, et al.,

Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction
Eur Heart J, 2009.
X. Bai, et al.,

Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial
Eur Heart J, 2009. 30(11): p. 1331-9.
S. D. Anker, et al.,

Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Circulation, 2009. 120(3): p. 194-200.
S. Zaman, et al.,

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial
Circulation, 2009. 119(14): p. 1933-40.
J. Mehilli, et al.,

Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy
Circulation, 2009. 120(19): p. 1875-82.
A. Maehara, et al.,

Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke
Circulation, 2009. 120(14): p. 1373-9.
J. M. Lightwood and S. A. Glantz,

Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective
Circulation, 2009. 119(9): p. 1211-9.
R. J. Goldberg, et al.,

Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial
Circulation, 2009. 120(11): p. 964-72.
E. Di Lorenzo, et al.,

Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Circulation, 2009. 119(25): p. 3207-14.
K. Y. Chen, et al.,

Strain-encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction
Circ Cardiovasc Imaging, 2009. 2(2): p. 116-22.
M. Neizel, et al.,

Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion
Chest, 2009. 135(6): p. 1488-95.
C. H. Lee, et al.,

Impact of day versus night as intervention time on the outcomes of primary angioplasty for acute myocardial infarction
Catheter Cardiovasc Interv, 2009. 74(6): p. 826-34.
H. Uyarel, et al.,

A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction
Catheter Cardiovasc Interv, 2009.
P. Osmancik, et al.,

Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial
Catheter Cardiovasc Interv, 2009. 74(3): p. 398-405.
J. Kanakakis, et al.,

In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program
Catheter Cardiovasc Interv, 2009. 74(2): p. 335-43.
A. K. Hassan, et al.,

Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction
Catheter Cardiovasc Interv, 2009. 73(5): p. 627-34.
M. L. Fokkema, et al.,

Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction
Am J Cardiol, 2009. 103(12): p. 1651-6.
A. Villa, et al.,

Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary intervention
Am J Cardiol, 2009. 103(1): p. 1-4.
D. Tzivoni, et al.,

Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)
Am J Cardiol, 2009. 103(6): p. 785-90.
N. Taglieri, et al.,

Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study)
Am J Cardiol, 2009. 103(11): p. 1495-9.
P. K. Stein and P. Deedwania,

Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction
Am J Cardiol, 2009. 103(10): p. 1333-8.
D. S. Sim, et al.,

Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
Am J Cardiol, 2009. 104(5): p. 634-7.
S. Samimi-Fard, et al.,

Trends in atrial fibrillation complicating acute myocardial infarction
Am J Cardiol, 2009. 104(2): p. 169-74.
J. S. Saczynski, et al.,

Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine
Am J Cardiol, 2009. 104(7): p. 910-6.
G. G. Rhoads, et al.,

Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Am J Cardiol, 2009. 104(9): p. 1198-203.
S. S. Rathore, et al.,

Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction
Am J Cardiol, 2009. 103(4): p. 461-3.
J. C. Quinaglia e Silva, et al.,

Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction
Am J Cardiol, 2009. 104(10): p. 1336-42.
M. Plewka, et al.,

Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study)
Am J Cardiol, 2009. 103(2): p. 181-6.
M. R. Patel, et al.,

Effectiveness of primary percutaneous coronary interventions for stent thrombosis
Am J Cardiol, 2009. 103(7): p. 913-6.
G. Parodi, et al.,

The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
Am J Cardiol, 2009. 104(9): p. 1179-83.
S. Orn, et al.,

A simple prognostic classification model for postprocedural complications after percutaneous coronary intervention for acute myocardial infarction (from the New York State percutaneous coronary intervention database)
Am J Cardiol, 2009. 103(7): p. 937-42.
A. Negassa, E. S. Monrad and V. S. Srinivas,

Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling
Am J Cardiol, 2009. 104(8): p. 1023-9.
R. Q. Migrino, et al.,

Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
Am J Cardiol, 2009. 103(3): p. 316-21.
R. G. McKay, et al.,

Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Am J Cardiol, 2009. 103(2): p. 165-9.
E. I. Lev, et al.,

Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry)
Am J Cardiol, 2009. 104(2): p. 182-9.
J. H. Lee, et al.,

Prognostic impact of Q waves on presentation and ST resolution in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Am J Cardiol, 2009. 104(6): p. 780-5.
S. Kumar, et al.,

Combined prognostic utility of white blood cell count, plasma glucose, and glomerular filtration rate in patients undergoing primary stent placement for acute myocardial infarction
Am J Cardiol, 2009. 103(3): p. 322-7.
M. Kosuge, et al.,

Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry)
Am J Cardiol, 2009. 104(8): p. 1074-7.
O. Koeth, et al.,

Ethnic variation in acute myocardial infarction presentation and access to care
Am J Cardiol, 2009. 103(10): p. 1368-73.
K. M. King, N. A. Khan and H. Quan,

Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction
Am J Cardiol, 2009. 103(1): p. 17-21.
T. M. Khumri, et al.,

Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction
Am J Cardiol, 2009. 104(2): p. 205-9.
Y. B. Juwana, et al.,

Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus
Am J Cardiol, 2009. 104(6): p. 769-74.
M. Ishihara, et al.,

Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention
Am J Cardiol, 2009. 103(11): p. 1525-9.
M. Imazio, et al.,

Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention
Am J Cardiol, 2009. 103(6): p. 779-84.
A. K. Hassan, et al.,

Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction
Am J Cardiol, 2009. 104(4): p. 486-91.
T. Hasin, et al.,

Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention
Am J Cardiol, 2009. 103(8): p. 1073-7.
A. Garcia-Alvarez, et al.,

Predicting irreversible left ventricular dysfunction after acute myocardial infarction
Am J Cardiol, 2009. 103(9): p. 1206-9.
D. R. Frisch, et al.,

The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction
Am J Cardiol, 2009. 104(6): p. 791-7.
V. E. Friedewald, et al.,

Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction
Am J Cardiol, 2009. 104(4): p. 514-8.
P. Fefer, et al.,

Comparison between myocardial contrast echocardiography and (99m)technetium sestamibi single photon emission computed tomography determined myocardial viability in predicting hard cardiac events following acute myocardial infarction
Am J Cardiol, 2009. 104(9): p. 1184-8.
G. Dwivedi, et al.,

Effect of coronary collaterals on microvascular obstruction as assessed by magnetic resonance imaging in patients with acute ST-elevation myocardial infarction treated by primary coronary intervention
Am J Cardiol, 2009. 104(9): p. 1204-9.
S. Desch, et al.,

Effect of acute myocardial infarction on erythrocytic glutathione peroxidase 1 activity and plasma vitamin e levels
Am J Cardiol, 2009. 103(4): p. 471-5.
M. L. Cheng, et al.,

Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction
Am J Cardiol, 2009. 104(3): p. 327-32.
J. M. Cheng, et al.,

Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling
Am J Cardiol, 2009. 104(1): p. 19-23.
S. A. Chang, et al.,

Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)
Am J Cardiol, 2009. 104(4): p. 507-13.
M. A. Cavender, et al.,

Comparison of effects of primary coronary angioplasty on left ventricular remodeling and heart failure in patients <70 versus > or =70 years with acute myocardial infarction
Am J Cardiol, 2009. 104(7): p. 926-31.
N. Carrabba, et al.,

Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry)
Am J Cardiol, 2009. 103(6): p. 766-71.
F. Cardarelli, et al.,

Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)
Am J Cardiol, 2009. 104(2): p. 151-7.
R. M. Califf, et al.,

Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial
Am J Cardiol, 2009. 104(2): p. 210-5.
M. Busk, et al.,

Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction
Am J Cardiol, 2009. 104(8): p. 1035-40.
A. S. Binbrek, et al.,

Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients
Am J Cardiol, 2009. 103(11): p. 1506-12.
M. Bertini, et al.,

Impact of time to reperfusion after acute myocardial infarction on myocardial damage assessed by left ventricular longitudinal strain
Am J Cardiol, 2009. 104(4): p. 480-5.
M. Bertini, et al.,

Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction
Am J Cardiol, 2009. 104(7): p. 904-9.
O. Barthelemy, et al.,

Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction
Am J Cardiol, 2009. 103(4): p. 455-60.
J. A. Barrabes, et al.,

Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction
Am J Cardiol, 2009. 104(8): p. 1013-7.
D. Aronson, et al.,

Usefulness of three posterior chest leads for the detection of posterior wall acute myocardial infarction
Am J Cardiol, 2009. 103(2): p. 159-64.
R. A. Aqel, et al.,

A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction
Am J Cardiol, 2009. 103(10): p. 1374-80.
A. Ahmed and B. Pitt,

Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?
Am Heart J, 2009. 157(6): p. 1088-96.
R. A. Weir, et al.,

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction
Am Heart J, 2009. 158(3): p. 356-63.
J. H. Traverse, et al.,

Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction
Am Heart J, 2009. 157(2): p. 327-33.
F. Schiele, et al.,

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry
Am Heart J, 2009. 158(4): p. 569-75.
T. Rakowski, et al.,

Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
Am Heart J, 2009. 157(6): p. 1074-80.
A. B. Osherov, et al.,

Real-time 3-dimensional echocardiography early after acute myocardial infarction: incremental value of echo-contrast for assessment of left ventricular function
Am Heart J, 2009. 157(5): p. 882 e1-8.
G. Nucifora, et al.,

Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program
Am Heart J, 2009. 157(3): p. 495-501.
K. J. Mukamal, et al.,

Effect of thrombus aspiration on infarct size and left ventricular function in high-risk patients with acute myocardial infarction treated by percutaneous coronary intervention. Results of a prospective controlled pilot study
Am Heart J, 2009. 157(3): p. 583 e1-7.
J. Lipiecki, et al.,

Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome
Am Heart J, 2009. 157(3): p. 569-575 e1.
C. Lettieri, et al.,

Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery
Am Heart J, 2009. 158(4): p. 680-7.
J. N. Katz, et al.,

Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure
Am Heart J, 2009. 158(4): p. 546-53.
P. A. Heidenreich, et al.,

Volumetric evaluation of coronary plaque in patients presenting with acute myocardial infarction or stable angina pectoris-a multislice computerized tomography study
Am Heart J, 2009. 157(3): p. 481-7.
S. Hammer-Hansen, et al.,

Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction
Am Heart J, 2009. 157(4): p. 763-70.
A. Goyal, et al.,

Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006
Am Heart J, 2009. 157(1): p. 185-194 e2.
G. C. Fonarow, W. J. French and P. D. Frederick,

Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty
Am Heart J, 2009. 158(5): p. 806-13.
I. Eitel, et al.,

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy
Am Heart J, 2009. 157(3): p. 541-7.
T. Dill, et al.,

Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial
Am Heart J, 2009. 158(4): p. e43-50.
E. Di Lorenzo, et al.,

Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors
Am Heart J, 2009. 158(3): p. 416-21.
G. De Luca, et al.,

Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access
Am Heart J, 2009. 158(5): p. 829-35.
M. Dalby, et al.,

The Toronto score for in-hospital mortality after percutaneous coronary interventions
Am Heart J, 2009. 157(1): p. 156-63.
S. Chowdhary, et al.,

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
Am Heart J, 2009. 158(5): p. 755-60.
S. J. Brener, et al.,

Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Am Heart J, 2009. 158(1): p. 84-91.
E. Appelbaum, et al.,

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
Lancet, 2009. 374(9696): p. 1149-59.
R. Mehran, et al.,

Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms
JAMA, 2009. 301(5): p. 487-8.
G. Ndrepepa, et al.,

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention
JAMA, 2009. 301(17): p. 1779-89.
R. H. Mehta, et al.,

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006
JAMA, 2009. 302(7): p. 767-73.
H. M. Krumholz, et al.,

Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction
JAMA, 2009. 301(15): p. 1556-64.
M. Kosiborod, et al.,

The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention
JACC Cardiovasc Interv, 2009. 2(10): p. 925-30.
A. M. Ross, et al.,

Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals
JACC Cardiovasc Interv, 2009. 2(10): p. 917-24.
H. C. Herrmann, et al.,

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial
JACC Cardiovasc Interv, 2009. 2(10): p. 909-16.
S. G. Ellis, et al.,

Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction
J Am Coll Cardiol, 2009. 53(1): p. 1-9.
W. Wojakowski, et al.,

Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction
J Am Coll Cardiol, 2009. 54(2): p. 130-8.
H. Tsujioka, et al.,

Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2)
J Am Coll Cardiol, 2009. 54(19): p. 1763-9.
M. Sejersten, et al.,

Incremental value of copeptin for rapid rule out of acute myocardial infarction
J Am Coll Cardiol, 2009. 54(1): p. 60-8.
T. Reichlin, et al.,

Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
J Am Coll Cardiol, 2009. 54(24): p. 2296-302.
S. H. Pedersen, et al.,

Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients
J Am Coll Cardiol, 2009. 53(16): p. 1425-36.
R. Marfella, et al.,

Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study
J Am Coll Cardiol, 2009. 54(14): p. 1271-9.
L. Marcoff, et al.,

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction
J Am Coll Cardiol, 2009. 54(24): p. 2277-86.
J. M. Hare, et al.,

Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance
J Am Coll Cardiol, 2009. 54(23): p. 2145-53.
M. Francone, et al.,

Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
J Am Coll Cardiol, 2009. 54(15): p. 1438-46.
G. Dangas, et al.,

Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances Results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction)
J Am Coll Cardiol, 2009.
E. Bohmer, et al.,

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
J Am Coll Cardiol, 2009. 53(17): p. 1503-9.
P. W. Armstrong, et al.,

Optical frequency domain imaging guided crossing of a stumpless chronic total occlusion
Int J Cardiol, 2009.
P. Tyczynski, et al.,

Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality
Heart, 2009. 95(5): p. 370-6.
F. Saia, et al.,

Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study
Heart, 2009. 95(24): p. 2014-22.
A. Rosengren, et al.,

Long-term effects of the Niigata-Chuetsu earthquake in Japan on acute myocardial infarction mortality: an analysis of death certificate data
Heart, 2009. 95(24): p. 2009-13.
I. Nakagawa, et al.,

Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study
Heart, 2009. 95(14): p. 1145-52.
K. Krause, et al.,

Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation
Heart, 2009. 95(13): p. 1079-84.
H. Kaneda, et al.,

The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP)
Heart, 2009. 95(7): p. 559-63.
S. Horne, et al.,

Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery
Heart, 2009. 95(19): p. 1612-8.
S. L. Hetherington, et al.,

Comparison of delayed enhancement patterns on multislice computed tomography immediately after coronary angiography and cardiac magnetic resonance imaging in acute myocardial infarction
Heart, 2009. 95(8): p. 624-9.
M. Habis, et al.,

Dual-phase multi-detector computed tomography assesses jeopardised and infarcted myocardium subtending infarct-related artery early after acute myocardial infarction
Heart, 2009. 95(18): p. 1495-501.
K. R. Chiou, et al.,

The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction
Heart, 2009. 95(11): p. 895-9.
K. P. Champney, et al.,

Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study
Heart, 2009. 95(6): p. 461-7.
B. Buckley and A. W. Murphy,

Predictors of infarct artery patency after prehospital thrombolysis: the multicentre, prospective, observational OPTIMAL study
Heart, 2009. 95(10): p. 799-806.
V. Bongard, et al.,

Smoking in relation to ST-segment elevation acute myocardial infarction: findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions
Heart, 2009. 95(12): p. 1006-11.
L. Bjorck, et al.,

Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study
Heart, 2009. 95(24): p. 1983-9.
J. O. Beitnes, et al.,

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries
Eur Heart J, 2009.
P. Widimsky, et al.,

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
Eur Heart J, 2009. 30(10): p. 1187-94.
A. A. Voors, et al.,

Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial
Eur Heart J, 2009. 30(5): p. 594-9.
M. Vogelzang, et al.,

Pharmaco-invasive vs. facilitated percutaneous coronary intervention strategies for ST-segment-elevation acute myocardial infarction patients in the new ESC Guidelines
Eur Heart J, 2009. 30(23): p. 2817.
A. Tofield,

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial
Eur Heart J, 2009. 30(11): p. 1313-21.
M. Tendera, et al.,

Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events
Eur Heart J, 2009. 30(3): p. 321-9.
P. G. Steg, et al.,

Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis
Eur Heart J, 2009. 30(18): p. 2213-9.
P. R. Sinnaeve, et al.,